Allergic Conjunctivitis Market is expected USD 2 Billion market by 2025

ROSWELL, Ga. - April 9, 2019 - PRLog -- Get Free Customization in This Report

Allergic conjunctivitis unusually caused when a person's eye comes in contact with an allergen (substances that cause allergies, like pollen, chemicals, dirt or mold spores) as the conjunctiva is prone to irritation from allergens. The eye becomes inflamed and sore. In conjunctivitis, the tissue (conjunctiva) that lines inside of the eyelid and the white of the eyeball that keeps the eyeball and eyelid moist became inflamed. Allergic Conjunctivitis Market will exceed US$ 2 Billion mark by the end of year 2025.

Conjunctivitis is one of the most common and treatable eye conditions. There are two types of conjunctivitis namely allergic and infective conjunctivitis. Further, allergic conjunctivitis is classified as acute and chronic conjunctivitis. Acute conjunctivitis is a short term condition and can cause generally during allergy season while chronic conjunctivitis can occur year-round and has a milder response to allergens. Common symptoms of chronic conjunctivitis include same as acute conjunctivitis i.e. burning and itching of the eyes and light sensitivity but it comes and goes more frequently.

Allergic conjunctivitis is different from infective conjunctivitis as the cause is different. Allergic conjunctivitis is not contagious like the infective one. So it is vital to know whether the affected person have allergic or infective conjunctivitis since treatment for each condition is different.

For More Information:

https://www.renub.com/allergic-conjunctivitis-market-p.php

In the latest Renub Research report, Allergic Conjunctivitis Market, the report offers an in-depth primer of its upcoming market including how the allergic conjunctivitis market has grown and what it holds for the future, along with the key factors that are driving the market growth and challenges which are restraining the market growth.

Irrespective of age, one who is susceptible to allergens, are more likely to develop allergic conjunctivitis, mostly the children and young adults. According to the Asthma and Allergy Foundation of America, allergies affect nearly 30 percent of adults and 40 percent of children and often run in families. If anyone who have allergies and live in locations with high pollen counts, they are more prone to allergic conjunctivitis.

On an estimate, allergic conjunctivitis nearly affects 20 percent of the world's population. The treatment given for allergic conjunctivitis includes medication for eye inflammation and its redness. The incidence of allergic conjunctivitis around the world is increasing due to increasing usage of chemicals and pollution resulting from rapid industrialization, urbanization and climate change. Further, rising awareness regarding allergic conjunctivitis among people and a medical professional is also expected to drive allergic conjunctivitis market positively over the forecast period.

Changing the lifestyle of the people and growth in the number of allergic conjunctivitis target patients are among the key factors driving the growth of Global Allergic Conjunctivitis Market. Owing to the increasing target patient, pharmaceutical companies are actively developing drugs to meet the growing patient's demand. However, the high cost associated with clinical trials in developing drugs act as one of the major restrains for the Global Allergic Conjunctivitis Market.

Client can Purchase this Report in Sections from below link:

Access full Research: https://www.renub.com/allergic-conjunctivitis-market-p.php

Market Summary:

•    Patient Population wise, China dominates the global allergic conjunctivitis patient population. The report provides patient population & population share for following countries: India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain.

•    Country wise market, United States is the leading country in the global allergic conjunctivitis market. This research report covers following market and market share of following countries: India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain.

•    Disease type: SAC and PAC holds largest market share This research report covers following diseases market and market share: Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC).

•    Drugs Profile and Pipe Line covered in the report are, Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266 and SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.

•    Company-wise the report provides overview, initiatives and financial insights of Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals and Ocular Therapeutix.

Key Topics Covered :

1.    Executive Summary

2.    Global Allergic Conjunctivitis Market and Patients Analysis

3.    Share Analysis – Global Allergic Conjunctivitis

4.    India

5.    China

6.    Japan

7.    United States

8.    United Kingdom

9.    France

10.    Germany

11.    Italy

12.    Spain

13.    Disease Type – Global Allergic Conjunctivitis Market

14.    Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs

15.    Growth Driver

16.    Challenges

17.    Santen Pharmaceutical

18.    Alcon Inc. (Novartis)

19.    Portola Pharmaceuticals Inc.

20.    Ocular Therapeutix Inc.

Contact Us

Email: info@renub.com

Phone: +1-678-302-0700

Web: www.renub.com